Pay in 4 interest-free payments of $5.89 Learn more
Ships within 48 hours · Estimated delivery Aug 4 - Aug 9
176 GLP-1RAs and diseases As a rising star in recent years, GLP-1RAs are not only effective in metabolic diseases but also play a role in non-metabolic disorders, affecting multiple systems including the musculoskeletal, nervous, cardiovascular, and digestive systems, and can even have implications in oncological diseases
You should consult your GP if you experience: Persistent difficulty managing blood glucose despite lifestyle modifications Unexplained weight gain or inability to lose weight despite sustained efforts Symptoms of diabetes (excessive thirst, frequent urination, unexplained fatigue) Family history of type 2 diabetes combined with other risk factors Important safety considerations : GLP-1 receptor agonists are prescription medications with potential adverse effects, most commonly gastrointestinal symptoms (nausea, vomiting, diarrhoea)
Plus, the long-term benefits of a whole-foods, high-fiber diet far outweigh any minimal risk posed by these compounds
Tirzepatide functions as an imbalanced dual agonist, characterised by a molecular structure exhibiting a markedly higher affinity for the GIP receptor than the GLP-1 receptor
Availability: Larger-volume orders are subject to current inventory
The blood sugar benefits are excellent, and the weight loss is a meaningful bonus that improves overall diabetes management
